Poonawalla Reaps Riches In Vaccine Rollouts
Cyrus Poonawalla has another passion besides horses and cars — making jabs for the masses.
Cyrus Poonawalla has another passion besides horses and cars — making jabs for the masses.
GEMCOVAC-OM is the first booster Covid-19 vaccine developed in India against the highly transmissible Omicron variant.
Serum Institute chief executive Adar Poonawalla, during a media event today, said the company has 200 million doses of vaccine stock available currently.
While 65.65 crore Indians have taken both the doses, first dose has been taken by 91.08 crore people.
100 crore shots and rising.
Covaxin gets approval for 2-18 year olds; limited clinical trials may be inadequate to detect issues, say experts.
At a time when the entire world is frantically trying to procure more vaccine doses, it is going to be a protracted struggle for India.
As India starts the second phase of its Covid-19 vaccine deployment, the question on the viability of its supply chain network, and its cold storage capability, has become more pertinent than ever.
Godrej & Boyce has built an array of made-in-India ultra-low temperature freezers for the world.
Prices of vaccines may crash in the next few months. The vaccine makers will have to strike while the iron is hot.